Hauptinvestoren

  • Aeris Capital Equity Investments - 18,74%
  • LSP Curetis Pooling - 18,17%
  • Forbion Capital Fund 2 Cooperatief - 8,93%
  • HBM BioCapital 2 Management - 8,43%
  • Aviva - 7,24%
  • Roche Finanz AG - 6,22%
  • Federal Republic of Germany - 5,97%
  • BioMedPartners - 5,68%
  • CD-VentureGmbH - 2,97%

Letztes Update: 24. Dezember 2015